KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) ("KalVista") today announced the pricing of an underwritten offering of 5,500,000 shares of its common stock at a price of $10.00 per share to certain ...
Now that the Fall Classic is over, we're flipping the page to our annual Way-Too-Early Power Rankings. We're ranking the teams based on where they stand entering the offseason -- one in which Juan ...